Literature DB >> 10074124

Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters.

H Höfelmayr1, L J Strobl, C Stein, G Laux, G Marschall, G W Bornkamm, U Zimber-Strobl.   

Abstract

Epstein-Barr virus nuclear antigen 2 (EBNA2) is essential for B-cell immortalization by EBV, most probably by its ability to transactivate a number of cellular and viral genes. EBNA2-responsive elements (EBNA2REs) have been identified in several EBNA2-regulated viral promoters, each of them carrying at least one RBP-Jkappa recognition site. RBP-Jkappa recruits EBNA2 to the EBNA2RE and, once complexed to EBNA2, is converted from a repressor into an activator. An activated form of the cellular receptor Notch also interacts with RBP-Jkappa, providing a link between EBNA2 and Notch signalling. To determine whether activated Notch is able to transactivate EBNA2-responsive viral promoters, we performed cotransfection experiments with activated mouse Notch1 (mNotch1-IC) and luciferase constructs of the BamHI C, LMP1, and LMP2A promoters. We present here evidence that mNotch1-IC transactivates viral promoters known to be regulated by EBNA2. As shown for EBNA2, mutations or deletions of the RBP-Jkappa sites diminish or eliminate mNotch1-IC-mediated transactivation of the promoters, pointing to an essential role for Notch-RBP-Jkappa interaction. In addition to RBP-Jkappa, other cellular factors may bind within the EBNA2REs of viral promoters. While some factors appear to play an important role in both EBNA2- and mNotch1-IC-mediated transactivation, others are only important for the activity of either EBNA2 or mNotch1-IC. We could observe specific mNotch1-IC-responsive regions, thereby throwing more light upon which cofactors interact with EBNA2 and mNotch1-IC, thus enabling them to become functionally transactivators in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074124      PMCID: PMC104034     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors.

Authors:  L A Milner; R Kopan; D I Martin; I D Bernstein
Journal:  Blood       Date:  1994-04-15       Impact factor: 22.113

2.  The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1.

Authors:  L Li; L A Milner; Y Deng; M Iwata; A Banta; L Graf; S Marcovina; C Friedman; B J Trask; L Hood; B Torok-Storb
Journal:  Immunity       Date:  1998-01       Impact factor: 31.745

3.  Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation.

Authors:  E M Fuentes-Pananá; P D Ling
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

4.  Nuclear access and action of notch in vivo.

Authors:  G Struhl; A Adachi
Journal:  Cell       Date:  1998-05-15       Impact factor: 41.582

5.  The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor.

Authors:  S Dou; X Zeng; P Cortes; H Erdjument-Bromage; P Tempst; T Honjo; L D Vales
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

6.  Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences.

Authors:  R Fåhraeus; A Jansson; A Sjöblom; T Nilsson; G Klein; L Rymo
Journal:  Virology       Date:  1993-07       Impact factor: 3.616

Review 7.  Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.

Authors:  L J Strobl; H Höfelmayr; C Stein; G Marschall; M Brielmeier; G Laux; G W Bornkamm; U Zimber-Strobl
Journal:  Immunobiology       Date:  1997-12       Impact factor: 3.144

8.  RBP-L, a transcription factor related to RBP-Jkappa.

Authors:  S Minoguchi; Y Taniguchi; H Kato; T Okazaki; L J Strobl; U Zimber-Strobl; G W Bornkamm; T Honjo
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

9.  Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines.

Authors:  A Bigas; D I Martin; L A Milner
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

10.  Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain.

Authors:  E H Schroeter; J A Kisslinger; R Kopan
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

View more
  26 in total

1.  A role for SKIP in EBNA2 activation of CBF1-repressed promoters.

Authors:  S Zhou; M Fujimuro; J J Hsieh; L Chen; S D Hayward
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Notch signalling via RBP-J promotes myeloid differentiation.

Authors:  T Schroeder; U Just
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

Review 3.  The expression and function of Epstein-Barr virus encoded latent genes.

Authors:  L S Young; C W Dawson; A G Eliopoulos
Journal:  Mol Pathol       Date:  2000-10

4.  Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta.

Authors:  Yao Chang; Heng-Huan Lee; Shih-Shin Chang; Tsuey-Ying Hsu; Pei-Wen Wang; Yu-Sun Chang; Kenzo Takada; Ching-Hwa Tsai
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent.

Authors:  Sabine Maier; Maja Santak; Anja Mantik; Kristina Grabusic; Elisabeth Kremmer; Wolfgang Hammerschmidt; Bettina Kempkes
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  An auto-regulatory loop for EBV LMP2A involves activation of Notch.

Authors:  Leah J Anderson; Richard Longnecker
Journal:  Virology       Date:  2007-11-05       Impact factor: 3.616

7.  Human Cytomegalovirus Infection Dysregulates the Localization and Stability of NICD1 and Jag1 in Neural Progenitor Cells.

Authors:  Xiao-Jun Li; Xi-Juan Liu; Bo Yang; Ya-Ru Fu; Fei Zhao; Zhang-Zhou Shen; Ling-Feng Miao; Simon Rayner; Stéphane Chavanas; Hua Zhu; William J Britt; Qiyi Tang; Michael A McVoy; Min-Hua Luo
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

8.  Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.

Authors:  Pamela M Pegman; Sinéad M Smith; Brendan N D'Souza; Sinéad T Loughran; Sabine Maier; Bettina Kempkes; Paul A Cahill; Matthew J Simmons; Céline Gélinas; Dermot Walls
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

9.  Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide.

Authors:  Christopher J Farrell; Jae Myun Lee; Eui-Cheol Shin; Marek Cebrat; Philip A Cole; S Diane Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

10.  High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes.

Authors:  Daniel Salamon; Maria Takacs; Fritz Schwarzmann; Hans Wolf; Janos Minarovits; Hans Helmut Niller
Journal:  Virus Genes       Date:  2003-08       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.